Legal & General Group
STSA

Legal & General Group’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Legal & General Group’s Portfolio STSA Stock Details STSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-897
Closed -$5K – 3704
2021
Q1 		$5K Hold
897
– – ﹤0.01% 3488
2020
Q4 		$4K Hold
897
– – ﹤0.01% 3453
2020
Q3 		$3K Sell
897
-617
-41% -$12.4K ﹤0.01% 3424
2020
Q2 		$44K Buy
1,514
+969
+178% +$22.4K ﹤0.01% 2761
2020
Q1 		$11K Sell
545
-365
-40% -$8.29K ﹤0.01% 3141
2019
Q4 		$18K Buy
+910
New +$12.9K ﹤0.01% 3215

Other funds holding STSA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Legal & General Group's STSA Position: Q2 2021 in Review

Legal & General Group sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q2 2021, closing a stake of 897 shares — an estimated $5K sold.

Legal & General Group first reported a position in STSA in Q4 2019 and held it in 6 quarters. The position peaked at $44K in Q2 2020. 60 funds tracked by Wall St. Rank hold STSA as of Q2 2021.

  • Legal & General Group reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Legal & General Group sold 897 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $5K.
  • Legal & General Group first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 6 quarters.
  • Legal & General Group's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $44K in Q2 2020.
  • 60 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.